Mark J. Gergen - Executive Chairman, Director at Poseida Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Executive Chairman, Director
Stock Symbol
PSTX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mark J. Gergen since 9/17/2023

Holdings reported by Mark J. Gergen for Poseida Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 651K $2.69M $4.13 Mar 1, 2024 Direct
Stock Option (Right to buy) 173K Jan 2, 2024 Direct Common Stock

Transactions reported by Mark J. Gergen for Poseida Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.